PTK2 and non-small cell lung carcinoma: Our study showed that ENO1 is overexpressed in NSCLC tissues, and upregulated ENO1 promotes cell glycolysis, proliferation, migration, invasion, and tumorigenicity via the FAK/PI3K/AKT pathway.